{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T22:37:32Z","timestamp":1717886252514},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2334-14-55","type":"journal-article","created":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T18:01:33Z","timestamp":1391277693000},"source":"Crossref","is-referenced-by-count":6,"title":["IFN- alpha blocks IL-17 production by peripheral blood mononuclear cells in patients with chronic active hepatitis B Infection"],"prefix":"10.1186","volume":"14","author":[{"given":"Fang","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangping","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,1]]},"reference":[{"key":"3008_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.bpg.2011.02.012","volume":"25","author":"V Calvaruso","year":"2011","unstructured":"Calvaruso V, Craxi A: Fibrosis in chronic viral hepatitis. Best Pract Res Clin Gastroenterol. 2011, 25: 219-230. 10.1016\/j.bpg.2011.02.012.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5 Suppl.","key":"3008_CR2","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1002\/hep.22962","volume":"49","author":"AM Di Bisceglie","year":"2009","unstructured":"Di Bisceglie AM: Hepatitis B and hepatocellular carcinoma. Hepatology. 2009, 49 (5 Suppl.): S56-S60.","journal-title":"Hepatology"},{"key":"3008_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/hep.23273","volume":"51","author":"JY Zhang","year":"2010","unstructured":"Zhang JY, Zhang Z, Lin F, et al: Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2010, 51: 81-91. 10.1002\/hep.23273.","journal-title":"Hepatology"},{"key":"3008_CR4","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s10875-010-9416-3","volume":"30","author":"Y Ye","year":"2010","unstructured":"Ye Y, Xie X, Yu J, et al: Involvement of Th17 and Th1 effector responses in patients with Hepatitis B. J Clin Immunol. 2010, 30: 546-555. 10.1007\/s10875-010-9416-3.","journal-title":"J Clin Immunol"},{"key":"3008_CR5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.clim.2009.11.012","volume":"134","author":"S Hirohata","year":"2010","unstructured":"Hirohata S, Shibuya H, Tejima S: Suppressive influences of IFN-\u03b1lpha on IL-17 expression in human CD4+ T cells. Clin Immunol. 2010, 134: 340-344. 10.1016\/j.clim.2009.11.012.","journal-title":"Clin Immunol"},{"key":"3008_CR6","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1182\/blood.V87.11.4731.bloodjournal87114731","volume":"87","author":"MJ Aman","year":"1996","unstructured":"Aman MJ, Tretter T, Eisenbeis I, et al: Interferon-alpha stimulates production of interleukin-10 in activated CD4\u2009+\u2009T cells and monocytes. Blood. 1996, 87: 4731-4736.","journal-title":"Blood"},{"key":"3008_CR7","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1084\/jem.174.4.915","volume":"174","author":"MR de Waal","year":"1991","unstructured":"de Waal MR, Haanen J, Spits H, et al: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med. 1991, 174: 915-924. 10.1084\/jem.174.4.915.","journal-title":"J Exp Med"},{"key":"3008_CR8","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.4049\/jimmunol.154.3.1280","volume":"154","author":"S Beissert","year":"1995","unstructured":"Beissert S, Hosoi J, Grabbe S, Asahina A, Granstein RD: IL-10 inhibits tumor antigen presentation by epidermalantigen-presenting cells. J Immunol. 1995, 154: 1280-1286.","journal-title":"J Immunol"},{"key":"3008_CR9","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/ni1540","volume":"8","author":"DC Fitzgerald","year":"2007","unstructured":"Fitzgerald DC, Zhang GX, El-Behi M, et al: Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol. 2007, 8: 1372-1379. 10.1038\/ni1540.","journal-title":"Nat Immunol"},{"key":"3008_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","volume":"50","author":"European Association for the Study of the Liver","year":"2009","unstructured":"European Association for the Study of the Liver: EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol. 2009, 50: 227-242.","journal-title":"J Hepatol"},{"key":"3008_CR11","doi-asserted-by":"crossref","unstructured":"Asian-Pacific consensus statement on the management of chronic hepatitisB: a 2012 update. Hepatol Int. 2012, 6: 531-56. 10.1007\/s12072-012-9365-4.","DOI":"10.1007\/s12072-012-9365-4"},{"key":"3008_CR12","doi-asserted-by":"publisher","first-page":"e18909","DOI":"10.1371\/journal.pone.0018909","volume":"6","author":"L Zhao","year":"2011","unstructured":"Zhao L, Tang Y, You Z, et al: Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression. PLoS One. 2011, 6: e18909-10.1371\/journal.pone.0018909.","journal-title":"PLoS One"},{"key":"3008_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s10875-009-9328-2","volume":"30","author":"J Ge","year":"2010","unstructured":"Ge J, Wang K, Meng QH, et al: Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol. 2010, 30: 60-67. 10.1007\/s10875-009-9328-2.","journal-title":"J Clin Immunol"},{"key":"3008_CR14","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/j.1440-1746.2009.06154.x","volume":"25","author":"W Wu","year":"2010","unstructured":"Wu W, Li J, Chen F, et al: Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. J Gastroenterol Hepatol. 2010, 25: 750-757. 10.1111\/j.1440-1746.2009.06154.x.","journal-title":"J Gastroenterol Hepatol"},{"key":"3008_CR15","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/icb.2010.63","volume":"88","author":"J Li","year":"2010","unstructured":"Li J, Wu W, Peng G, et al: HBcAg induces interleukin-10 production, inhibiting HBcAg-specific Th17 responses in chronic hepatitis B patients. Immunol Cell Biol. 2010, 88: 834-841. 10.1038\/icb.2010.63.","journal-title":"Immunol Cell Biol"},{"key":"3008_CR16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M, Kuchroo VK: IL-17 and Th17 Cells. Annu Rev Immunol. 2009, 27: 485-517. 10.1146\/annurev.immunol.021908.132710.","journal-title":"Annu Rev Immunol"},{"key":"3008_CR17","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jbspin.2009.03.012","volume":"76","author":"O Meyer","year":"2009","unstructured":"Meyer O, et al: Interferons and autoimmune disorders. Joint Bone Spine. 2009, 76: 464-473. 10.1016\/j.jbspin.2009.03.012.","journal-title":"Joint Bone Spine"},{"key":"3008_CR18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2165\/00003495-199142050-00003","volume":"42","author":"NB Finter","year":"1991","unstructured":"Finter NB, Chapman S, Dowd P, et al: The use of interferon-alpha in virus infections. Drugs. 1991, 42: 749-765. 10.2165\/00003495-199142050-00003.","journal-title":"Drugs"},{"key":"3008_CR19","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.4049\/jimmunol.0802226","volume":"182","author":"X Zhang","year":"2009","unstructured":"Zhang X, Jin J, Tang Y, Speer D, Sujkowska D, Markovic-Plese S: IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation. J Immunol. 2009, 182: 3928-3936. 10.4049\/jimmunol.0802226.","journal-title":"J Immunol"},{"key":"3008_CR20","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.intimp.2008.02.003","volume":"8","author":"G Penton-Rol","year":"2008","unstructured":"Penton-Rol G, Cervantes-Llanos M, Cabrera-Gomez JA, et al: Treatment with type I interferons induces a regulatory T cell subset in peripheral blood mononuclear cells frommultiple sclerosis patients. Int Immunopharmacol. 2008, 8: 881-886. 10.1016\/j.intimp.2008.02.003.","journal-title":"Int Immunopharmacol"},{"key":"3008_CR21","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.bbrc.2009.12.081","volume":"391","author":"N Kubota","year":"2010","unstructured":"Kubota N, Ebihara T, Matsumoto M, et al: IL-6 and IFN-\u03b1lpha from dsRNA-stimulated dendritic cells control expansion of regulatory T cells. Biochem Biophys Res Commun. 2010, 391: 1421-1426. 10.1016\/j.bbrc.2009.12.081.","journal-title":"Biochem Biophys Res Commun"},{"key":"3008_CR22","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1189\/jlb.0307157","volume":"82","author":"J Pirhonen","year":"2007","unstructured":"Pirhonen J, Siren J, Julkunen I, Matikainen S: IFN-\u03b1lpha regulates Toll-like receptor-mediated IL-27 gene expression in human macrophages. J Leukoc Biol. 2007, 82: 1185-1192. 10.1189\/jlb.0307157.","journal-title":"J Leukoc Biol"},{"key":"3008_CR23","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.4049\/jimmunol.0801162","volume":"182","author":"C Diveu","year":"2009","unstructured":"Diveu C, McGeachy MJ, Boniface K, et al: IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J Immunol. 2009, 182: 5748-5756. 10.4049\/jimmunol.0801162.","journal-title":"J Immunol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-55\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-55.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-55","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-55.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T05:55:48Z","timestamp":1688968548000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3008"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-55","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,1]]},"article-number":"55"}}